Fampridine
Sponsors
Assistance Publique Hopitaux De Paris, Biogen, University College Dublin, Centre Hospitalier Universitaire de Besancon, Genesis Pharma CNS & Specialty
Conditions
Gastrointestinal Stromal TumorsMultiple SclerosisPregnancyPrimary Progressive Multiple SclerosisSecondary Progressive Multiple SclerosisSpinocerebellar ataxiamultiple sclerosis
nerve disease
Phase 1
Phase 2
Phase 3
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
CompletedNCT02219932
Start: 2014-09-30End: 2016-02-29Updated: 2017-03-27
A randomized, parallel-arm, double blind, placebo-controlled study to assess the efficacy of fampridine for patients with spinocerebellar ataxia SCA27B caused by a GAA expansion in the FGF14 gene.(TREAT-FGF14)
RecruitingCTIS2024-520413-53-00
Start: 2025-10-21Target: 70Updated: 2025-08-01
Phase 4
Open-Label Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) on Quality of Life as Reported by Participants With Multiple Sclerosis
CompletedNCT01480076
Start: 2012-02-29End: 2013-08-31Updated: 2017-03-21
A Study of the Effectiveness of Fampridine in Improving Upper Limb Function in MS
CompletedNCT02208050
Start: 2014-02-21End: 2016-02-16Updated: 2021-07-09
Short and Long Term Multiple Outcomes in Persons With Multiple Sclerosis Treated by Fampridine.
CompletedNCT02849782
Start: 2014-02-04End: 2019-03-01Updated: 2021-02-02
Unknown Phase
An Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra (BIIB041) When Used In Routine Medical Practice
CompletedNCT01480063
Start: 2012-04-16End: 2019-02-08Updated: 2019-06-05
Fampridine Pregnancy Exposure Registry
TerminatedNCT01532154
Start: 2015-08-31End: 2016-02-29Updated: 2016-10-18
Fampridine in MS Patients: A Cognition, Fatigue, Depression and Quality of Life Analysis
CompletedNCT03164018
Start: 2017-03-07End: 2018-12-15Updated: 2019-02-15
Muscle Strain in Multiple Sclerosis Patients Measured by Ultrasound Speckle Tracking Technique
CompletedNCT03847545
Start: 2018-12-12End: 2021-10-15Updated: 2022-04-05